Yigal Nochomovitz
Stock Analyst at Citigroup
(3.03)
# 1,400
Out of 4,749 analysts
285
Total ratings
40.27%
Success rate
1.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $33 | $7.65 | +331.37% | 1 | Jan 7, 2025 | |
| MRUS Merus | Maintains: Buy | $89 → $97 | $40.94 | +136.93% | 16 | Dec 9, 2024 | |
| APLT Applied Therapeutics | Maintains: Buy | $13 → $8 | $0.59 | +1,264.02% | 10 | Nov 29, 2024 | |
| CRBU Caribou Biosciences | Maintains: Buy | $30 → $6 | $1.43 | +319.58% | 5 | Nov 26, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $37 → $45 | $14.17 | +217.57% | 7 | Nov 19, 2024 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $40 → $49 | $21.65 | +126.33% | 10 | Nov 12, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $63 → $51 | $29.01 | +75.80% | 14 | Nov 6, 2024 | |
| KRYS Krystal Biotech | Maintains: Neutral | $204 → $206 | $159.74 | +28.96% | 3 | Nov 5, 2024 | |
| ARDX Ardelyx | Maintains: Buy | $12 → $10 | $5.36 | +86.57% | 14 | Nov 4, 2024 | |
| ZYME Zymeworks | Maintains: Buy | $16 → $18 | $14.60 | +23.29% | 15 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $8.02 | +236.66% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.16 | +72.41% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 → $23 | $21.50 | +6.98% | 4 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $28.54 | +26.14% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $24.35 | +138.19% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $4.18 | +426.32% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $3.00 | +366.67% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.66 | +80.89% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $12.90 | +194.57% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $84 | $41.59 | +101.97% | 20 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $10.42 | +34.36% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.12 | -5.44% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $25.53 | +33.18% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $27.19 | +142.74% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $36 → $55 | $17.61 | +212.32% | 8 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $16.97 | +182.85% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $6.11 | +227.33% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.24 | +52.67% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $3.74 | -73.25% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $8.88 | +294.14% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $43.03 | +209.09% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.76 | +957.92% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $2.22 | +170.27% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.61 | +893.79% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.30 | +669.23% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.65 | +869.70% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $5.56 | +691.37% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.83 | +555.74% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.89 | - | 14 | Sep 28, 2021 |
EyePoint Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $7.65
Upside: +331.37%
Merus
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $40.94
Upside: +136.93%
Applied Therapeutics
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.59
Upside: +1,264.02%
Caribou Biosciences
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.43
Upside: +319.58%
Syndax Pharmaceuticals
Nov 19, 2024
Maintains: Buy
Price Target: $37 → $45
Current: $14.17
Upside: +217.57%
Rigel Pharmaceuticals
Nov 12, 2024
Maintains: Buy
Price Target: $40 → $49
Current: $21.65
Upside: +126.33%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $29.01
Upside: +75.80%
Krystal Biotech
Nov 5, 2024
Maintains: Neutral
Price Target: $204 → $206
Current: $159.74
Upside: +28.96%
Ardelyx
Nov 4, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $5.36
Upside: +86.57%
Zymeworks
Nov 4, 2024
Maintains: Buy
Price Target: $16 → $18
Current: $14.60
Upside: +23.29%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $8.02
Upside: +236.66%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.16
Upside: +72.41%
Sep 27, 2024
Downgrades: Neutral
Price Target: $19 → $23
Current: $21.50
Upside: +6.98%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $28.54
Upside: +26.14%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $24.35
Upside: +138.19%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $4.18
Upside: +426.32%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $3.00
Upside: +366.67%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.66
Upside: +80.89%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $12.90
Upside: +194.57%
May 23, 2024
Maintains: Buy
Price Target: $89 → $84
Current: $41.59
Upside: +101.97%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $10.42
Upside: +34.36%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.12
Upside: -5.44%
Apr 10, 2024
Initiates: Buy
Price Target: $34
Current: $25.53
Upside: +33.18%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $27.19
Upside: +142.74%
Feb 15, 2024
Downgrades: Neutral
Price Target: $36 → $55
Current: $17.61
Upside: +212.32%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $16.97
Upside: +182.85%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $6.11
Upside: +227.33%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.24
Upside: +52.67%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $3.74
Upside: -73.25%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $8.88
Upside: +294.14%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $43.03
Upside: +209.09%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.76
Upside: +957.92%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $2.22
Upside: +170.27%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.61
Upside: +893.79%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.30
Upside: +669.23%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $1.65
Upside: +869.70%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $5.56
Upside: +691.37%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.83
Upside: +555.74%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.89
Upside: -